ROBERTO DELA CRUZ: Open Payments
NPI 1912101577 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 16 payments from 10 companies in 2025. Trend: 2023 $14 · 2024 $371 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| ABBVIE INC. | 2 | $43 |
| Exact Sciences Corporation | 1 | $32 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Novo Nordisk Inc | 2 | $31 |
| Lilly USA, LLC | 2 | $28 |
| PFIZER INC. | 1 | $26 |
| Abbott Laboratories | 1 | $25 |
| SANOFI PASTEUR INC. | 1 | $24 |
| Amgen Inc. | 1 | $16 |
Products named: QULIPTA, Cologuard Collection Kit, MOUNJARO, PREVNAR 20, FREESTYLE LIBRE 3, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FARXIGA, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
